The Pharmaceutical Journal speaks about P1vital® PReDicT Test
The Pharmaceutical Journal examines personalised treatment to depression including P1vital® PReDicT Test which is being used in PReDicT clinical study across 5 European countries.
i-spero® brings together decades of clinical research and proven artificial intelligence to deliver digital tools that improve recovery rates for patients whilst reducing the overall cost of treatment.
The Pharmaceutical Journal examines personalised treatment to depression including P1vital® PReDicT Test which is being used in PReDicT clinical study across 5 European countries.
Following ECNP Congress where Catherine J. Harmer, DPhil talked about early change in emotional processing predicting antidepressant response.
University of Nottingham, MindTech article talks about PReDicT study and the P1vital® PReDicT Test.
We are very excited to announce we have won a trade show stand at 2017 BIO International Convention.
